MARKET

ZLDAF

ZLDAF

Zelira Therapeutics Limited
OTCMQB
0.333
NaN%
Closed 09:30 03/26 EDT
OPEN
--
PREV CLOSE
0.333
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
0.479
52 WEEK LOW
0.191
MARKET CAP
3.78M
P/E (TTM)
-1.2562
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at ZLDAF last week (0317-0321)?
Weekly Report · 2d ago
Weekly Report: what happened at ZLDAF last week (0310-0314)?
Weekly Report · 03/17 09:31
Bearish Sentiment Across The Cannabis Space - Check Full Movers For March 13, 2025
Benzinga · 03/13 20:30
Weekly Report: what happened at ZLDAF last week (0303-0307)?
Weekly Report · 03/10 09:32
Watching Cannabis Stocks; Marijuana Moment Reports 'Trump White House Invites Proposal On Federal Marijuana Legalization, Activist Says'
Benzinga · 03/05 17:38
Weekly Report: what happened at ZLDAF last week (0224-0228)?
Weekly Report · 03/03 09:32
Zelira Therapeutics Advances Autism Drug Program with FDA Support and Patent Secures
TipRanks · 02/26 09:38
Weekly Report: what happened at ZLDAF last week (0217-0221)?
Weekly Report · 02/24 09:32
More
About ZLDAF
Zelira Therapeutics Limited is an Australia-based biopharmaceutical company. The Company is engaged in the research, development and commercialization of clinically validated cannabinoid-based medicines. It owns a portfolio of products and a pipeline of candidates undergoing clinical development positioned to enter global markets. It is focused on developing and clinically validating branded cannabinoid-based medicines in its prescription (Rx) business for the treatment of a variety of medical conditions, including insomnia, autism and chronic non-cancer pain, as well as offering over the counter (OTC) products. It has two medications: HOPE and ZENIVOL. ZENIVOL is a cannabinoid-based medicine for the treatment of chronic insomnia. The Company in partnership with SprinJeneCBD, introduced a full line of oral care products, including SprinJeneCBD toothpaste product, which is a hemp-derived, oral care products containing cannabinoids, blackseed oil and zinc utilizing patented technology.

Webull offers Zelira Therapeutics Ltd stock information, including OTCMQB: ZLDAF real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ZLDAF stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ZLDAF stock methods without spending real money on the virtual paper trading platform.